No description available.

No description available.

No description available.

No description available.

Glucocorticoid activation of two types of adrenocorticosteroid receptors (ACRs), themineralocorticoid receptor (MR) and the glucocorticoid receptor (GR), influences hippocampalneuron vulnerability to injury. Excessive activation of GR may compromise hippocampalneuron survival after several types of challenge including ischemic, metabolic, and excitotoxicinsults. In contrast, MR prevents adrenalectomy-induced loss of granule neurons in the dentategyrus. The present thesis addresses the respective roles of MR and GR in modulating neuronalsurvival following two forms of neuronal injury, excitotoxicity and traumatic brain injury. MaleSprague-Dawley rats were pretreated with MR antagonist spironolactone or GR antagonistmifepristone (RU486) and subsequently injected with kainic acid, an excitotoxic glutamateanalog, or injured with a controlled cortical impact. Twenty-four hours following injury,hippocampal neuron survival was measured to test the hypotheses that MR blockade wouldendanger and GR blockade would protect hippocampal neurons following injury. MessengerRNA levels of viability-related genes including bcl-2, bax, p53, BDNF, and NT-3 were alsomeasured to test the hypothesis that ACR regulation of these genes wouldcorrelate with neuronal survival. In addition, ACR mRNA levels were measured followingreceptor blockade and injury to test the hypothesis that glucocorticoid signaling is alteredfollowing neuronal injury via regulation of ACR expression.Mineralocorticoid receptor blockade with spironolactone increased neuronal vulnerability toexcitotoxic insult in hippocampal field CA3, and GR blockade with RU486 prevented neuronalloss after traumatic brain injury in field CA1. These results are consistent with the hypothesesthat MR protects and GR endangers hippocampal neurons. Adrenocorticosteroid receptorblockade decreased mRNA levels of the anti-apoptotic gene bcl-2 in select regions of uninjuredhippocampus, yet ACR regulation of bcl-2 did not consistently correspond with measures ofneuronal survival after injury. Kainic acid decreased MR mRNA levels in CA1 and CA3, whileboth kainic acid and controlled cortical impact dramatically decreased GR mRNA levels indentate gyrus. These data suggest that injury modulation of glucocorticoid signaling throughregulation of ACR expression may influence hippocampal neuron viability following injury.

We investigated licking and grooming (LG) levels received by each pup from their dams and the locomotor activity, anxiety-like behaviors, and stress reactivity in adult female offspring. We also investigated glucocorticoid receptor (GR) gene expression and its DNA methylation status in the hippocampus, comparing pups between and with-in litters. Rats that receive more LG than their siblings showed less anxiety-like behaviors and increased locomotor activity, regardless of their litter type. Higher licked pups also showed increased expression of the GR gene. Gene expression levels of the GR 17 splice variant were not significantly different as a function of dam LG or LG received, whereas DNA methylation levels at two CpG sites within GR17 promoter were significantly higher in high LG pups than low LG pups. Our results indicate that naturally occurring intra- and inter-litter differences in maternal LG have a lasting effect on the phenotypic outcomes of adult female offspring.

We investigated licking and grooming (LG) levels received by each pup from their dams and the locomotor activity, anxiety-like behaviors, and stress reactivity in adult female offspring. We also investigated glucocorticoid receptor (GR) gene expression and its DNA methylation status in the hippocampus, comparing pups between and with-in litters. Rats that receive more LG than their siblings showed less anxiety-like behaviors and increased locomotor activity, regardless of their litter type. Higher licked pups also showed increased expression of the GR gene. Gene expression levels of the GR 17 splice variant were not significantly different as a function of dam LG or LG received, whereas DNA methylation levels at two CpG sites within GR17 promoter were significantly higher in high LG pups than low LG pups. Our results indicate that naturally occurring intra- and inter-litter differences in maternal LG have a lasting effect on the phenotypic outcomes of adult female offspring.

Glucocorticoids are mammalian steroid hormones secreted from the adrenal gland. The basal levels of glucocorticoids show a pronounced diurnal rhythm with maximum at the beginning of the active period and minimum at its end. Glucocorticoids have an influence over a variety of metabolic functions and their secretion is tightly regulated. This regulation also depends on the circadian system, which utilizes glucocorticoids to entrain the peripheral tissues by inducing rhythmic gene expression. The mechanisms by which glucocorticoids influence mammalian circadian system has not yet been precisely defined, especially concerning the influence of glucocorticoid signalling on gene expression in different tissues and the dynamics of glucocorticoid receptor (GR) occupancy. This thesis studies the influence of ablation of glucocorticoid signalization induced by adrenalectomy on the clock gene expression of in the central clock in the suprachiasmatic nucleus and peripheral clocks in the hippocampus and distal colon. The effect of adrenalectomy on gene expression is compared with the effect of restricting the feeding time, which has also been shown to affect glucocorticoid levels in the body. Other experiments were aimed at elucidating impact of changing the activity of GR on gene expression using synthetic GR...

In recent years, endocrine disruption of corticosteroid signaling pathways in wildlife and humans by environmental chemicals have attracted increasing attention. The integrated potential of chemicals in the aquatic environment that disrupt corticosteroid actions have been evaluated using in vitro glucocorticoid receptor (GR) mediated bioassays. Exogenous natural and synthetic corticosteroids (CSs), which are widely used in human and animal therapeutic applications, were demonstrated to be the most important GR agonists, that can potentially cause adverse effects, especially on aquatic organisms. To date, only a few studies have investigated the occurrence and behavior of GR agonists in the aquatic environment and their removal in conventional wastewater treatment plants. Furthermore, there are hardly any data reported on the removal of GR agonists by advanced water and wastewater treatment, especially those synthetic CSs with high potency. To further understand the fate of GR agonists in water and wastewater treatment processes, a sensitive and robust LC-MS/MS method was successfully developed for analyzing a wide range of GR agonists in various environmental waters. The occurrence of GR agonists in surface water and groundwater was monitored along the Lower Santa Cruz River (SCR). Several GR agonists were detected, and a trend of degradation was observed downstream the two WWTP outfalls for both surface water and groundwater. The fate of GR agonists in a local wastewater treatment plant (WWTP) was investigated, and up to 14 GR agonists were detected at different stages. Highly potent synthetic CSs, including clobetasol propionate (CBP), fluticasone propionate (FTP), fluocinolone acetonide (FCA), and triamcinolone acetonide (TCA), were poorly removed in WWTP. Negative removal of some CSs was observed in primary treatment, which may due to the deconjugation of CS conjugates. Removal of GR agonists in secondary effluent during various advanced water treatment processes, including UV, ozonation, MF, RO and chlorination, were studied. UV and RO appeared to be the most efficient treatment process for the attenuation of GR agonists, followed by ozone, while chlorination had little effects on GR agonists in water. Bench-scale experiments were then carried out to investigate the removal of GR agonists by ultraviolet based advanced oxidation processes (UV/AOPs), and powder activated carbon (PAC). UV/chlorine and UV/H2O2 were demonstrated to be effective in removal GR agonists in wastewater, and UV photolysis would be the predominant mechanism in UV/AOP processes. Four types of PACs were tested for removing GR agonists in wastewater effluent, and Cabot HDB carbon was suggested, while Calgon PWA carbon was not recommended due to its low removal efficiency.

Les hormones ovariennes sont impliquées dans le développement du cancer du sein des femmes porteuses de mutations du gène BRCA1. L’étude du tissu mammaire normal de femmes mutées et non mutées nous a permis de montrer des altérations de la signalisation de l’estradiol et la progestérone dans un modèle de greffes chez la souris. Ces dérégulations concernent l’activité proliférative et l’expression des récepteurs hormonaux, et sont hétérogènes d’une patiente mutée à l’autre. De plus, une diminution de l’expression de la forme phosphorylée en sérine 211 du récepteur des glucocorticoïdes a été mise en évidence dans le tissu muté BRCA1. Ces observations posent la question de la place d’unantiprogestatif/anti-glucocorticoïde tel que l’ulipristal acétate (UPA) dans le traitement préventif des femmes mutées pour BRCA1. Les effets de l’UPA ont été caractérisés in vitro dans les cellules mammaires normales pour préciser les conséquences de son utilisation sur le sein. Son action a ensuite été examinée sur les xénogreffes de sein de patientes mutées et non mutées. Nous montrons que l’UPA est capable d’inhiber la prolifération du tissu muté lorsqu’elle est induite par la progestérone. Ce résultat encourage son utilisation dans la prévention tumorale mais indique une spécificité d’action en fonction des dérégulations hormonales associées au tissu muté. / Ovarian hormones, estradiol and progesterone, are known to promote breast carcinogenesis in BRCA1 mutated women. Using normal mammary gland xenografted in mice, we found that hormonal responses were deregulated in a heterogeneous fashion within BRCA1 mutation carriers. These observations raise the question of a potential use ofantiprogestin treatment as ulipristal acetate (UPA) to prevent breast tumorigenesis in BRCA1mutated women. Studies with this experimental model and epithelial normal breast cells in vitro, revealed that UPA alone had no proliferative activity on breast tissue but was efficient to inhibit proliferative activity when induced by progesterone treatment in mutated tissue. UPAcould be a promising treatment to prevent breast tumorigenesis for some mutated women. In addition, we observed a severe decrease of the phosphorylated Serine 211 glucocorticoid receptor isoform in BRCA1 carriers compared to non mutated tissue. This observation suggests that the glucocorticoid receptor expression and activation should be taken intoaccount in BRCA1 carriers.